Ahmed Merzouk

Dr. Merzouk holds a PhD in Organic Chemistry from University of Paris-Sud (Paris-XI), France. He has more than 18 years’ experience in industry and academia in drug discovery of small and large molecules. The expertise of Dr. Merzouk ranges from design, synthesis, and purification of synthetic molecules to extraction of active ingredients from natural sources. Dr. Merzouk was the previous Chemistry Director of Chemokine Therapeutics Corp. for eight years. He was responsible for the design and the synthesis of active analogues that were derived from the Chemokine’s family of proteins. Two of lead compounds that resulted from his work reached phase- II clinical trials (CTC9908, and CTCE0214). Dr. Merzouk has authored more than 17 peer-reviewed journals as well as 22 issued and pending US and PCT patents.